Clinical trial No longer in our active list Interventional Ages 18 to 65 Women only

Comparing different electrical stimulation methods for treating overactive bladder in women

Official title: The Effectiveness of Parassacral Transcutaneous Stimulation Compared to Tibial Transcutaneous Stimulation, Home Protocol and Behavioral Therapy in the Treatment of Female Hyperative Bladder: Randomized Clinical Trial

Run by Centro de Atenção ao Assoalho Pélvico · NCT04909047 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing different electrical stimulation methods to see which one helps women with overactive bladder feel better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment120 (estimated)
SponsorCentro de Atenção ao Assoalho Pélvico
Academic / other
Locations3 sites (Salvador, Bahia and 2 other locations)
Trial IDNCT04909047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 to 65 who experience symptoms of overactive bladder.

Probably not a fit

Patients with cognitive deficits, psychiatric illnesses, or those with specific medical conditions such as chronic renal failure or pregnancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of parassacral transcutaneous stimulation compared to tibial transcutaneous stimulation and a home protocol for treating female overactive bladder. Women aged 18 to 65 with symptoms of overactive bladder will be randomized into three groups to assess the efficacy of these interventions. The study aims to provide insights into which method may offer better relief from urinary urgency symptoms. By comparing these approaches, the trial seeks to enhance treatment options for women suffering from this condition.

Why it matters

Potential benefit: If successful, this study could provide women with more effective treatment options for managing overactive bladder symptoms.

How similar studies have gone: While there are studies on the effectiveness of these stimulation methods individually, this trial aims to compare them directly, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with symptoms of overactive bladder, aged 18 to 65 years.

Exclusion Criteria:

* Participants who have difficulty understanding the stages of the research, report cognitive deficit or psychiatric illness, patients with congenital orthopedic / neurological diseases, overactive bladder due to neurological impairment, presence of lower urinary tract infection, sensory deficit in the sacral or tibial region, diagnosis of chronic renal failure, patients with pacemakers and implantable cardioverter defibrillators and pregnant women.

Where it's running

  • Cebtro de Atebçao ao Assolaho Pévico- Escola Bahiana de Medicina e Saúde Pública
    Salvador, Bahia, Brazil
    Recruiting
  • Centro de Atenção ao assoalho pélvico
    Salvador, Bahia, Brazil
    Recruiting
  • Centro de Atenção ao Assoalho Pelvico
    Salvador, Ba, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.